Roche Makes Hostile $5.7 Billion Offer for Illumina

Roche Holding AG offered about $5.7 billion in cash for Illumina Inc. to bolster cancer-drug sales, the third time since 2007 the Swiss drugmaker has made a hostile bid for a U.S. company.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.